BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,750
-140 (-1.01%)
Jan 19, 2026, 3:30 PM KST
-29.92%
Market Cap437.91B
Revenue (ttm)165.64B
Net Income (ttm)-7.70B
Shares Out31.85M
EPS (ttm)-242.14
PE Ration/a
Forward PE114.74
Dividendn/a
Ex-Dividend Daten/a
Volume153,782
Average Volume219,618
Open13,760
Previous Close13,890
Day's Range13,660 - 13,940
52-Week Range12,800 - 23,250
Beta0.73
RSI34.02
Earnings DateMar 13, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 650
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.